A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure

NCT02914665 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

308

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: elamipretide
DRUG: Placebo

Sponsor

Stealth BioTherapeutics Inc.